Skip to content

Genworth Financial

US · GNW #2349 by market cap Listed 1970
7.58 -0.11 -1.43%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Fair Value how this is computed

Near fair value
0.29 fair value ≈ 8.59 16.89
  • Implied fair-value range of 0.29-16.89, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -11.7% below the average-multiple fair value of 8.59.

Valuation each multiple against its own 5-year range

P/B ratio 0.35 In line with history 51st percentile
5-year average 0.32 · #6 of 22 in Insurance - Life
P/E ratio 55.53 Expensive vs history 94th percentile
5-year average 15.91 · forward 23.65 · #18 of 18 in Insurance - Life
P/S ratio 0.42 Expensive vs history 69th percentile
5-year average 0.38 · #7 of 22 in Insurance - Life

Vs. peers Insurance - Life

Company Market cap P/E (TTM) P/B Div yield
Genworth Financial (GNW) 2.78B 50.53 0.32 0.00%
Manulife Financial (MFC) 67.55B 16.80 2.04 3.26%
Aflac Inc (AFL) 61.49B 18.15 2.10 1.94%
MetLife (MET) 60.12B 12.51 2.71 2.43%
Prudential Financial (PRU) 40.38B 10.72 1.37 4.71%
Prudential (PUK) 29.79B 8.51 1.50 2.20%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value8.88 Economic moatNone UncertaintyHigh

Trading 17.2% below Morningstar's fair value estimate.

Fair value

Genworth Financial Inc earns a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 6% discount to our quantitative fair value estimate of $8.88 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's valuation metrics bolster our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 268.2% ranks in the top 10% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The firm's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 3.3, a core component of leverage, sits in the bottom 30% compared with peers globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Genworth Financial discussion 0 comments

Add a comment